recombinant human chorionic gonadotropin

DRUG4 trials

Sponsors

Fox Chase Cancer Center, University of California, San Diego, Ferring Pharmaceuticals

Conditions

BRCA1 MutationBreast CancerInfertilityPolycystic Ovary Syndrome

Phase 3

Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)

CompletedNCT00747617

University of California, San DiegoPolycystic Ovary Syndrome

Start: 2007-09-30End: 2010-09-30Updated: 2018-11-21

A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation

CompletedNCT02449889

Ferring PharmaceuticalsInfertility

Start: 2016-04-30End: 2018-03-01Updated: 2019-06-26

Unknown Phase

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

TerminatedNCT00700778

Fox Chase Cancer CenterBRCA1 Mutation, Breast Cancer

Start: 2008-07-31End: 2014-03-31Updated: 2021-01-25

Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome

CompletedNCT00989781

University of California, San DiegoPolycystic Ovary Syndrome

Start: 2009-09-30End: 2013-09-30Updated: 2018-06-04

Related Papers

Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.

2016-07-2611 citations

Decreased inhibin B responses following recombinant human chorionic gonadotropin administration in normal women and women with polycystic ovary syndrome.

2013-11-014 citations